LABA/ICS Combination (e.g., Fluticasone/Salmeterol)
Treatment for COPD
Effectiveness
75%
Safety Score
50%
Clinical Trials
1
Participants
60K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
0
LABA/ICS Combination (e.g., Fluticasone/Salmeterol) Outcomes
for COPD
Efficacy Outcomes
Overall Effectiveness
+75%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for LABA/ICS Combination (e.g., Fluticasone/Salmeterol) in COPD
WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects
NCT01763463COMPLETED
1 participants
OBSERVATIONAL
Started: Jul 1, 2012